Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria

by R. N. Price, A. R. Hasugian, A. Ratcliff, H. Siswantoro, H. L.E. Purba, E. Kenangalem, N. Lindegardh, P. Penttinen, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tjitra
Published 2018

Cost-effectiveness of artesunate for the treatment of severe malaria

by Y. Lubell, S. Yeung, A. M. Dondorp, N. P. Day, F. Nosten, E. Tjitra, Md Abul Faiz, E. Bin Yunus, N. M. Anstey, S. K. Mishra, S. Mohanty, N. J. White, A. J. Mills
Published 2018

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax

by R. Suwanarusk, M. Chavchich, B. Russell, A. Jaidee, F. Chalfein, M. Barends, B. Prasetyorini, E. Kenangalem, K. A. Piera, U. Lek-Uthai, N. M. Anstey, E. Tjitra, F. Nosten, Q. Cheng, R. N. Price
Published 2018

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum

by U. Lek-Uthai, R. Suwanarusk, R. Ruengweerayut, T. S. Skinner-Adams, F. Nosten, D. L. Gardiner, P. Boonma, K. A. Piera, K. T. Andrews, B. MacHunter, J. S. McCarthy, N. M. Anstey, R. N. Price, B. Russell
Published 2018